In-Vitro Fertilization (IVF) Services Market, Global Scenario, Market Size, Outlook, Trend and Forecast 2018-2026

CHAPTER 1: INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market Definition and Scope
3.2. IVF pricing trends
3.3. IVF Cycles by Country
3.4. Global IVF services market, by end user

3.4.1. Market size and forecast
3.4.2. Market volume and forecast
3.4.3. Fertility clinics

3.4.3.1. Market size and forecast

3.4.4. Hospitals

3.4.4.1. Market size and forecast

3.4.5. Surgical centers

3.4.5.1. Market size and forecast

3.4.6. Clinical research institutes

3.4.6.1. Market size and forecast

3.5. Global IVF services market by cycle type

3.5.1. Market size and forecast
3.5.2. Market volume and forecast
3.5.3. Fresh IVF cycles (non-donor)

3.5.3.1. Market size and forecast

3.5.4. Thawed IVF cycles (non-donor)

3.5.4.1. Market size and forecast

3.5.5. Donor egg IVF cycles

3.5.5.1. Market size and forecast

3.6. Market dynamics

3.6.1. Drivers

3.6.1.1. Delayed pregnancies in women
3.6.1.2. Increase in global infertility rates
3.6.1.3. Increase in gamete donations
3.6.1.4. Increase in disposable income
3.6.1.5. Increase in IVF success rates
3.6.1.6. Surge in healthcare expenditure worldwide

3.6.2. Restraints

3.6.2.1. Cost constraints
3.6.2.2. Complications associated with IVF treatment
3.6.2.3. Low awareness level

3.6.3. Opportunities

3.6.3.1. Fertility tourism
3.6.3.2. Growth opportunities in the emerging markets
3.6.3.3. Increase in number of fertility clinics
3.6.3.4. Rise in same sex marriage

3.6.4. Impact analyses

3.7. Key findings

CHAPTER 4: NORTH AMERICA IVF SERVICES MARKET

4.1. Overview

4.1.1. Market size and forecast

4.1.1.1. By country
4.1.1.2. By End User
4.1.1.3. By Cycle Type

4.1.2. Market volume and forecast

4.1.2.1. By Country
4.1.2.2. By End User
4.1.2.3. By Cycle Type

4.2. U.S. IVF services market, (Revenue and Number of Cycles)

4.2.1. Overview
4.2.2. Market size and forecast
4.2.3. Fertility Clinics in U.S., 2016
4.2.4. U.S. IVF services market, by end user

4.2.4.1. Market size and forecast
4.2.4.2. Market volume and forecast
4.2.4.3. Fertility clinics
4.2.4.4. Hospitals
4.2.4.5. Surgical Centers
4.2.4.6. Clinical Research Institutes

4.2.5. U.S. IVF services market, by cycle type

4.2.5.1. Market size and forecast
4.2.5.2. Market volume and forecast
4.2.5.3. Fresh IVF cycles (non-donor)
4.2.5.4. Thawed IVF cycles (non-donor)
4.2.5.5. Donor egg IVF cycles

4.2.6. Market dynamics

4.2.6.1. Driving factors

4.2.6.1.1. Increasing popularity of IVF in U.S.
4.2.6.1.2. Increased rate of infertility and practices of embryo banking cycles

4.2.6.2. Restraining Factors

4.2.6.2.1. High cost of IVF treatment in U.S.
4.2.6.2.2. Restrictions on 3-parent IVF treatments
4.2.6.2.3. Scattered Reimbursements

4.2.7. Regulatory Issues, Legislations and Authorities
4.2.8. Insurance Reimbursement Scenario
4.2.9. Company Profiles

4.2.9.1. Fertility and Gynecology Center Monterey Bay IVF

4.2.9.1.1. Company overview

4.2.9.2. Conceptions Reproductive Associates of Colorado

4.2.9.2.1. Company overview

4.2.9.3. Servy Massey Fertility Institute

4.2.9.3.1. Company overview

4.2.9.4. Sher Institute for Reproductive Medicine (SIRM)

4.2.9.4.1. Company overview

4.2.9.5. Cardone Reproductive Medicine and Infertility, LLC

4.2.9.5.1. Company overview

4.2.9.6. Fertility Center of San Antoni

4.2.9.6.1. Company overview

4.2.9.7. Houston Fertility Center

4.2.9.7.1. Company overview

4.2.9.8. New hope fertility center

4.2.9.8.1. Company overview

4.3. Canada IVF services market, (Revenue and Number of Cycles)

4.3.1. Overview
4.3.2. Market size and forecast
4.3.3. IVF Clinics in Canada
4.3.4. Canada IVF services market, by end user

4.3.4.1. Market size and forecast
4.3.4.2. Market volume and forecast
4.3.4.3. Fertility clinics
4.3.4.4. Hospitals
4.3.4.5. Surgical Centers
4.3.4.6. Clinical Research Institutes

4.3.5. Canada IVF services market, by cycle type

4.3.5.1. Market size and forecast
4.3.5.2. Market volume and forecast
4.3.5.3. Fresh IVF cycles (non-donor)
4.3.5.4. Thawed IVF cycles (non-donor)
4.3.5.5. Donor egg IVF cycles

4.3.6. Market Dynamics

4.3.6.1. Driving Factors

4.3.6.1.1. Commercialization of IVF booster in Canada

4.3.6.2. Restraining Factors

4.3.6.2.1. High cost of IVF treatment in Canada

4.3.7. Regulatory Issues, Legislations and Authorities
4.3.8. Insurance Reimbursement Scenario
4.3.9. Company Profiles

4.3.9.1. TRIO Fertility

4.3.9.1.1. Company overview

4.3.9.2. The Montreal Fertility Center

4.3.9.2.1. Company overview

4.3.9.3. Procrea Fertility

4.3.9.3.1. Company overview

4.3.9.4. IVF Canada

4.3.9.4.1. Company overview

4.4. Mexico IVF services market, (Revenue and Number of Cycles)

4.4.1. Overview
4.4.2. Market size and forecast
4.4.3. Fertility Clinics in Mexico
4.4.4. Mexico IVF services market, by end user

4.4.4.1. Market size and forecast
4.4.4.2. Market volume and forecast
4.4.4.3. Fertility clinics
4.4.4.4. Hospitals
4.4.4.5. Surgical Centers
4.4.4.6. Clinical Research Institutes

4.4.5. Mexico IVF services market, by cycle type

4.4.5.1. Market size and forecast
4.4.5.2. Market volume and forecast
4.4.5.3. Fresh IVF cycles (non-donor)
4.4.5.4. Thawed IVF cycles (non-donor)
4.4.5.5. Donor egg IVF cycles

4.4.6. Market Dynamics

4.4.6.1. Driving Factors

4.4.6.1.1. Fertility tourism
4.4.6.1.2. Comparatively low cost of IVF

4.4.6.2. Restraining Factors

4.4.6.2.1. Language Barriers

4.4.7. Regulatory Issues, Legislations and Authorities
4.4.8. Insurance Reimbursement Scenario
4.4.9. Company Profiles

4.4.9.1. LIV Fertility Center

4.4.9.1.1. Company overview

4.4.9.2. Biofertility Center

4.4.9.2.1. Company overview

4.4.9.3. Ivinsemer

4.4.9.3.1. Company overview

CHAPTER 5: EUROPE IVF SERVICES MARKET

5.1. Overview

5.1.1. Market size and forecast

5.1.1.1. By Country
5.1.1.2. By End User
5.1.1.3. By Cycle Type

5.1.2. Market volume and forecast

5.1.2.1. By Country
5.1.2.2. By End User
5.1.2.3. By Cycle Type

5.2. Germany IVF services market, (Revenue and Number of Cycles)

5.2.1. Overview
5.2.2. Market size and forecast
5.2.3. Fertility Clinics in Germany
5.2.4. Germany IVF services market, by end user

5.2.4.1. Market size and forecast
5.2.4.2. Market volume and forecast
5.2.4.3. Fertility clinics
5.2.4.4. Hospitals
5.2.4.5. Surgical Centers
5.2.4.6. Clinical Research Institutes

5.2.5. Germany IVF services market, by cycle type

5.2.5.1. Market size and forecast
5.2.5.2. Market volume and forecast
5.2.5.3. Fresh IVF cycles (non-donor)
5.2.5.4. Thawed IVF cycles (non-donor)

5.2.6. Market dynamics

5.2.6.1. Driving Factors

5.2.6.1.1. Subsidizing IVF treatments
5.2.6.1.2. Delayed marriages and parenthood decisions

5.2.6.2. Restraining Factors

5.2.6.2.1. Limited adoption of IVF methods

5.2.7. Regulatory Issues, Legislations and Authorities
5.2.8. Insurance Reimbursement Scenario
5.2.9. Company Profiles

5.2.9.1. Heidelberg University Hospital

5.2.9.1.1. Company overview

5.2.9.2. Wunschkinder

5.2.9.2.1. Company overview

5.2.9.3. Fertility Center Berlin

5.2.9.3.1. Company overview

5.2.9.4. amedes MVZ Cologne GmbH

5.2.9.4.1. Company overview

5.3. France IVF services market, (Revenue and Number of Cycles)

5.3.1. Overview
5.3.2. Market size and forecast
5.3.3. IVF Clinics in France
5.3.4. France IVF services market, by end user

5.3.4.1. Market size and forecast
5.3.4.2. Market volume and forecast
5.3.4.3. Fertility clinics
5.3.4.4. Hospitals
5.3.4.5. Surgical Centers
5.3.4.6. Clinical Research Institutes

5.3.5. France IVF services market, by cycle type

5.3.5.1. Market size and forecast
5.3.5.2. Market volume and forecast
5.3.5.3. Fresh IVF cycles (non-donor)
5.3.5.4. Thawed IVF cycles (non-donor)
5.3.5.5. Donor egg IVF cycles

5.3.6. Market Dynamics

5.3.6.1. Driving Factors

5.3.6.1.1. Rising adoption of IVF babies among same gender population
5.3.6.1.2. Lower rates of Fertility

5.3.6.2. Restraining Factors

5.3.6.2.1. Stringent government regulations

5.3.7. Regulatory Issues, Legislations and Authorities
5.3.8. Insurance Reimbursement Scenario
5.3.9. Company Profiles

5.3.9.1. Ambroise Par Group

5.3.9.1.1. Company overview

5.3.9.2. AMP Center St Roch

5.3.9.2.1. Company overview

5.4. UK IVF services market, (Revenue and Number of Cycles)

5.4.1. Overview
5.4.2. Market size and forecast
5.4.3. Fertility Clinics in UK
5.4.4. UK IVF services market, by end user

5.4.4.1. Market size and forecast
5.4.4.2. Market volume and forecast
5.4.4.3. Fertility clinics
5.4.4.4. Hospitals
5.4.4.5. Surgical Centers
5.4.4.6. Clinical Research Institutes

5.4.5. UK IVF services market, by cycle type

5.4.5.1. Market size and forecast
5.4.5.2. Market volume and forecast
5.4.5.3. Fresh IVF cycles (non-donor)
5.4.5.4. Thawed IVF cycles (non-donor)
5.4.5.5. Donor egg IVF cycles

5.4.6. Market Dynamics

5.4.6.1. Driving Factors

5.4.6.1.1. Commercialization of three-parent IVF procedures
5.4.6.1.2. Supportive Regulations

5.4.6.2. Restraining Factors

5.4.6.2.1. Ethical considerations

5.4.7. Regulatory Issues, Legislations and Authorities
5.4.8. Insurance Reimbursement Scenario
5.4.9. Company Profiles

5.4.9.1. The Lister Fertility Clinic

5.4.9.1.1. Company overview

5.4.9.2. The Bridge Centre

5.4.9.2.1. Company overview

5.4.9.3. Chelsea and Westminster Hospital (Assisted Conception Unit)

5.4.9.3.1. Company overview

5.5. Italy IVF services market, (Revenue and Number of Cycles)

5.5.1. Overview
5.5.2. Market size and forecast
5.5.3. Italy IVF services market, by end user

5.5.3.1. Market size and forecast
5.5.3.2. Market volume and forecast
5.5.3.3. Fertility clinics
5.5.3.4. Hospitals
5.5.3.5. Surgical Centers
5.5.3.6. Clinical Research Institutes

5.5.4. Italy IVF services market, by cycle type

5.5.4.1. Market size and forecast
5.5.4.2. Market volume and forecast
5.5.4.3. Fresh IVF cycles (non-donor)
5.5.4.4. Thawed IVF cycles (non-donor)
5.5.4.5. Donor egg IVF cycles

5.5.5. Market Dynamics

5.5.5.1. Driving Factors

5.5.5.1.1. Rise in medical tourism

5.5.5.2. Restraining Factors

5.5.5.2.1. Ban on Surrogacy

5.5.6. Regulatory Issues, Legislations and Authorities
5.5.7. Insurance Reimbursement Scenario
5.5.8. Company Profiles

5.5.8.1. The ARC-STER Center

<span style="box-sizing: border-box; font-family: Arial, Helve